Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer immunotherapy
4
×
clinical trials
fda
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
4
×
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
medicare
nivolumab
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech ipos
bristol-myers squibb
chronic kidney disease
eli lilly
pfizer
89bio
What
week
4
×
companies
ipo
life
science
bio
biotech
momentum
new
raised
research
roundup
alzheimer’s
annual
arena’s
arrival
assessed
attention
biotechs
bounty
cig
club
comeback
communities
conference
continued
corner
crop
days
deals
delivered
drug
esmo
europe
exceeded
expressing
firms
germany
group
hasn’t
Language
unset
Current search:
national
×
week
×
" san francisco blog main "
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M